The Reverse J-Shaped Association Between Serum Total 25-Hydroxyvitamin D Concentration and All-Cause Mortality: The Impact of Assay Standardization

被引:43
|
作者
Durazo-Arvizu, Ramon A. [1 ]
Dawson-Hughes, Bess [2 ]
Kramer, Holly [1 ]
Cao, Guichan [1 ]
Merkel, Joyce [3 ]
Coates, Paul M. [3 ]
Sempos, Christopher T. [3 ]
机构
[1] Loyola Univ, Stritch Sch Med, Dept Publ Hlth Sci, Chicago, IL 60611 USA
[2] Tufts Univ, Metab Lab, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[3] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
25(OH)D; 25-hydroxyvitamin D; mortality; NHANES; vitamin D; VDSP; Vitamin D Standardization Program; TANDEM MASS-SPECTROMETRY; VITAMIN-D STATUS; PROGRAM PROTOCOLS; MEN; COMMUNITY; D-3;
D O I
10.1093/aje/kww244
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We evaluated the impact of standardizing the originally measured serum total 25-hydroxyvitamin D (25(OH)D) values from Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994) on the association between 25(OH) D and rate of all-cause mortality. Values were standardized to the gold-standard laboratory method. Follow-up from 1990-2006 consisted of 15,099 participants aged at least 20 years at baseline, among whom there were 3,784 deaths. Relative risk of death was adjusted for age, sex, race/ethnicity, and season using Poisson regression. Results were obtained for eight 25(OH) D (nmol/L) categories: <20 nmol/L, 20-29 nmol/L, 30-39 nmol/L, 40-49 nmol/L, 50-59 nmol/L, 60-74 nmol/L, 75-99 nmol/L (reference), and = 100 nmol/L. Assay standardization dramatically shifted original 25(OH) D values toward zero. Accordingly, risk = 120 nmol/L could not be evaluated (i.e., n = 7 and ndeaths = 2). Relative risk (95% confidence interval (CI)) <40 nmol/L remained significant (30-39 nmol/L: relative risk (RR) = 1.4 (95% CI: 1.1, 1.6); 20-29 nmol/L: RR = 1.6 (95% CI: 1.3, 1.9), and <20 nmol/L: RR = 2.1 (95% CI: 1.6, 2.7). However, adjusted relative risk estimates for 25(OH) D levels = 40 nmol/L were no longer significant (40-49 nmol/L: RR = 1.2 (95% CI: 0.99, 1.4); 50-59 nmol/L: RR = 1.2 (95% CI: 1.04, 1.4); 60-74 nmol/L: RR = 1.1 (95% CI: 0.94, 1.2); 75-99 nmol/L: RR = 1.0 (referent), and = 100 nmol/L: RR = 1.1 (95% CI: 0.6, 2.1). In summary, after standardization, risk of death from all causes increased with decreasing 25(OH)D <40 nmol/L, while there was no association with values in categories between 40 nmol/L and 120 nmol/L.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 50 条
  • [1] A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study
    Durup, D.
    Jorgensen, H. L.
    Christensen, J.
    Schwarz, P.
    Heegaard, A. M.
    Lind, B.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08): : 2644 - 2652
  • [2] Is There a Reverse J-Shaped Association Between 25-Hydroxyvitamin D and All-Cause Mortality? Results from the U.S. Nationally Representative NHANES
    Sempos, Christopher T.
    Durazo-Arvizu, Ramon A.
    Dawson-Hughes, Bess
    Yetley, Elizabeth A.
    Looker, Anne C.
    Schleicher, Rosemary L.
    Cao, Guichan
    Burt, Vicki
    Kramer, Holly
    Bailey, Regan L.
    Dwyer, Johanna T.
    Zhang, Xinli
    Gahche, Jaime
    Coates, Paul M.
    Picciano, Mary Frances
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07): : 3001 - 3009
  • [3] A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study
    Durup, Darshana
    Jorgensen, Henrik Lovendahl
    Christensen, Jane
    Tjonneland, Anne
    Olsen, Anja
    Halkjaer, Jytte
    Lind, Bent
    Heegaard, Anne-Marie
    Schwarz, Peter
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (06): : 2339 - 2346
  • [4] A Reverse J-shaped Association Between Serum 25-hydroxyvitamin D and Cardiovascular Disease Mortality - the CopD Study.
    Durup, Darshana
    Jorgensen, Henrik L.
    Christensen, Jane
    Tjonneland, Anne
    Olsen, Anja
    Halkjaer, Jytte
    Lind, Bent
    Heegaard, Anne-Marie
    Schwarz, Peter
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S392 - S393
  • [5] Association of serum 25-hydroxyvitamin D concentration with all-cause and cause-specific mortality in hypertensive patients
    Pan, Dikang
    Qiao, Huan
    Wang, Hui
    Wu, Sensen
    Wang, Jingyu
    Wang, Cong
    Guo, Jianming
    Gu, Yongquan
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (05) : 1274 - 1282
  • [6] L-shaped association between serum 25-hydroxyvitamin D and all-cause mortality of individuals with rheumatoid arthritis
    Cai, Bin
    Zhou, Mengmeng
    Xiao, Qingqing
    Zou, Hejian
    Zhu, Xiaoxia
    [J]. RHEUMATOLOGY, 2022, : 575 - 582
  • [7] 25-Hydroxyvitamin D Levels and All-Cause Mortality
    Zittermann, Armin
    Grant, William B.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (11) : 1075 - 1076
  • [8] 25-Hydroxyvitamin D Levels and All-Cause Mortality Reply
    Melamed, Michal L.
    Michos, Erin D.
    Astor, Brad
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (11) : 1076 - 1076
  • [9] Relationship between 25-Hydroxyvitamin D and All-cause and Cardiovascular Disease Mortality
    Amer, Muhammad
    Qayyum, Rehan
    [J]. AMERICAN JOURNAL OF MEDICINE, 2013, 126 (06): : 509 - 514
  • [10] 25-Hydroxyvitamin D concentration and all-cause mortality: the Melbourne Collaborative Cohort Study
    Heath, Alicia K.
    Williamson, Elizabeth J.
    Kvaskoff, David
    Hodge, Allison M.
    Ebeling, Peter R.
    Baglietto, Laura
    Neale, Rachel E.
    Giles, Graham G.
    Eyles, Darryl W.
    English, Dallas R.
    [J]. PUBLIC HEALTH NUTRITION, 2017, 20 (10) : 1775 - 1784